|
Veridex LLC, based in Warren, New Jersey, is a Johnson & Johnson company that develops in vitro diagnostic oncology products. The firm's CellSearch (TM) diagnostic tests support the identification and characterization of circulating tumor cells. CellSearch technology, approved by the U.S. Food and Drug Administration (FDA) in 2004, allows users to evaluate disease progression. It also is used in developing treatment programs for patients with metastatic breast cancer. The CellSearch line includes the CellSave Preservative Tube, CellSearch Circulating Tumor Cell Kit, CellTracks (R) AutoPrep System, CellTracks Analyzer II, and CellSearch Circulating Tumor Cell Control Kit products. Veridex offers life science cancer researchers the CellSearch Profile Kit, CellSearch Circulating Endothelial Cell Kit, CellSearch Tumor Phenotyping Reagent MUC-1, and CellSearch Tumor Phenotyping Reagent EGFr products. The company's GeneSearch (TM) breast lymph node assay, built on molecular technologies, streamlines gene expression profiling processes. The intra-operative test provides users with reproducible results. The product is commercially available in Europe. Veridex has formed alliances with Immunicon Corporation and Cepheid.
|
Information Sources, Inc.